Literature DB >> 12703760

Voxel-guided morphometry ("VGM") and application to stroke.

Thorsten Schormann1, Matthias Kraemer.   

Abstract

Monitoring of cerebral diseases associated with a change of morphology (e.g., stroke) requires unprecedented accuracy for quantification of its morphological progression for each voxel. The purpose of this paper is to provide a technique [voxel-guided morphometry (VGM)] to quantify macroscopic anatomical differences. VGM consists of four steps: 1) coarse linear alignment by the extended principle axes theory (ePAT) generalized to affine movements; 2) a cross-correlation-based technique using a matrix-norm for fine linear alignment; 3) the applied high-dimensional multiresolution full multigrid method determines the nonlinear deformations, thereby achieving a complete exploitation of information and effective processing. The method measures a gray-value-guided movement of each voxel from source to target. The resulting high-dimensional deformation field is further processed by 4) determination of volume alterations for each voxel. Furthermore, the effect of linear registration errors on final morphometric measurements is discussed and the conditions for a bijective correspondence of voxels assuming small alterations are derived. To illustrate the technique the changing morphology of different subjects suffering from cerebral infarction is presented by using commonly available T1-weighted magnetic resonance volumes. VGM visualizes that ischemic as well as remote regions are affected by stroke.

Entities:  

Mesh:

Year:  2003        PMID: 12703760     DOI: 10.1109/TMI.2002.806571

Source DB:  PubMed          Journal:  IEEE Trans Med Imaging        ISSN: 0278-0062            Impact factor:   10.048


  7 in total

1.  Atrophy of spared gray matter tissue predicts poorer motor recovery and rehabilitation response in chronic stroke.

Authors:  Lynne V Gauthier; Edward Taub; Victor W Mark; Ameen Barghi; Gitendra Uswatte
Journal:  Stroke       Date:  2011-11-17       Impact factor: 7.914

2.  Size doesn't matter: cortical stroke lesion volume is not associated with upper extremity motor impairment and function in mild, chronic hemiparesis.

Authors:  Stephen J Page; Lynne V Gauthier; Susan White
Journal:  Arch Phys Med Rehabil       Date:  2013-01-18       Impact factor: 3.966

3.  A comparison of VLSM and VBM in a cohort of patients with post-stroke aphasia.

Authors:  Sharon Geva; Jean-Claude Baron; P Simon Jones; Cathy J Price; Elizabeth A Warburton
Journal:  Neuroimage Clin       Date:  2012-08-30       Impact factor: 4.881

4.  Mobilisation of hematopoietic CD34+ precursor cells in patients with acute stroke is safe--results of an open-labeled non randomized phase I/II trial.

Authors:  Sandra Boy; Sophie Sauerbruch; Mathias Kraemer; Thorsten Schormann; Felix Schlachetzki; Gerhard Schuierer; Ralph Luerding; Burkhard Hennemann; Evelyn Orso; Andreas Dabringhaus; Jürgen Winkler; Ulrich Bogdahn
Journal:  PLoS One       Date:  2011-08-26       Impact factor: 3.240

5.  Contralesional Cortical Structural Reorganization Contributes to Motor Recovery after Sub-Cortical Stroke: A Longitudinal Voxel-Based Morphometry Study.

Authors:  Jianxin Cai; Qiling Ji; Ruiqiang Xin; Dianping Zhang; Xu Na; Ruchen Peng; Kuncheng Li
Journal:  Front Hum Neurosci       Date:  2016-08-03       Impact factor: 3.169

6.  Intrahemispheric Perfusion in Chronic Stroke-Induced Aphasia.

Authors:  Cynthia K Thompson; Matthew Walenski; YuFen Chen; David Caplan; Swathi Kiran; Brenda Rapp; Kristin Grunewald; Mia Nunez; Richard Zinbarg; Todd B Parrish
Journal:  Neural Plast       Date:  2017-03-05       Impact factor: 3.599

7.  Individual Assessment of Brain Tissue Changes in MS and the Effect of Focal Lesions on Short-Term Focal Atrophy Development in MS: A Voxel-Guided Morphometry Study.

Authors:  Jan Fox; Matthias Kraemer; Thorsten Schormann; Andreas Dabringhaus; Jochen Hirsch; Philipp Eisele; Kristina Szabo; Christel Weiss; Michael Amann; Katrin Weier; Yvonne Naegelin; Ludwig Kappos; Achim Gass
Journal:  Int J Mol Sci       Date:  2016-04-01       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.